Scholar Rock (SRRK) affiliated fund adds 500,439 shares in Oct 2025
Rhea-AI Filing Summary
Srinivas Akkaraju, a director, reported multiple purchases of Scholar Rock Holding Corp (SRRK) common stock in early October 2025. The filings show net additions through affiliated vehicles, primarily Samsara Opportunity Fund, L.P., bringing the fund's reported beneficial ownership to 500,439 shares following purchases executed on 10/03/2025 and 10/06/2025. Purchase prices are disclosed as weighted averages across multiple trades, with reported ranges from $35.14 up to $39.84 depending on the tranche. The report also notes prior shares held by Samsara BioCapital, L.P. and contains standard disclaimers that the reporting person disclaims beneficial ownership except to the extent of pecuniary interest.
Positive
- Significant net purchases reported that increase the affiliated fund's stake to 500,439 shares
- Purchases executed across multiple dates (10/03/2025 and 10/06/2025), showing sustained buying activity
- Transparent pricing disclosure with weighted-average price ranges provided for each tranche
Negative
- Indirect ownership structure—shares are held by affiliated funds, and the reporting person disclaims beneficial ownership except for pecuniary interest
- Concentration in affiliated vehicles may limit clarity on the individual director's personal economic exposure
Insights
Material insider purchases concentrated in an affiliated fund raise reported stake to 500,439 shares.
The transactions were purchases executed on 10/03/2025 and 10/06/2025
and were recorded at weighted average prices ranging from $35.14 to $39.84. The buying activity is aggregated under Samsara Opportunity Fund, L.P., which the reporting person controls. For investors, the key mechanic is that these are fund-level acquisitions, not direct purchases by the individual, so voting and investment power are exercised through the fund.
Risks and dependencies include the indirect ownership structure and the reporting person’s disclaimer of beneficial ownership except for pecuniary interest, which limits how the purchases translate to the individual's personal exposure. Monitor quarterly disclosures and any Schedule 13 filings for changes in direct ownership or changes to the fund’s stake within Q4 2025.
Form 4 shows standard Section 16 reporting for a director with affiliated-entity holdings and disclaimers.
The filing identifies the reporter as a director and lists purchases attributed to controlled entities (Samsara Opportunity Fund and Samsara BioCapital). The form includes customary explanatory footnotes about weighted average prices and disclaimers of beneficial ownership where the reporter claims only pecuniary interest.
Governance implications: these entries should be read as fund-managed activity rather than unequivocal personal accumulation. Watch for any future amendments or related-party disclosures that change the characterization of voting or dispositive power in the near term (next SEC filing cycle).
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 18,414 | $37.89 | $698K |
| Purchase | Common Stock | 80,863 | $38.68 | $3.13M |
| Purchase | Common Stock | 13,748 | $39.52 | $543K |
| Purchase | Common Stock | 11,011 | $35.61 | $392K |
| Purchase | Common Stock | 56,703 | $36.74 | $2.08M |
| Purchase | Common Stock | 319,700 | $37.42 | $11.96M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $35.14 to $36.13 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote. Securities are directly held by Samsara Opportunity Fund, L.P. ("Samsara Opportunity Fund"). Samsara Opportunity Fund GP, LLC ("Samsara Opportunity GP") is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein. The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $36.14 to $37.1391 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $37.14 to $37.6227 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $37.23 to $38.2276 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $38.23 to $39.2298 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $39.23 to $39.84 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote. The shares held by Samsara BioCapital, L.P. ("Samsara LP") reflect the disposition of 310,086 shares previously reported as held by Samsara LP, in which the Reporting Person had no pecuniary interest. The transfer of such shares by Samsara LP did not involve a change in the Reporting Person's beneficial ownership of such shares and, accordingly, was exempt from reporting under Section 16. Shares held by Samsara LP. The Reporting Person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara LP. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
